X
Karan_Singh

Jubilant Pharmova Q4FY23; Reported Losses

Jubilant Pharmova Ltd.’s revenue in Q4FY23 rose 10% to ₹ 1,678 crores. Consolidated Loss After Tax came at ₹ 101 crores in Q4FY23.

Categories: AlphaGraphs Health Care
Tags: Radiopharma
Related Post
  1. NLC India Ltd Q2FY25; 10% fall in Profits

    NLC India is engaged in the business of mining of lignite and generation of power…

  2. NHPC Ltd Q2FY25; 37% fall in Profits

    NHPC, a Mini Ratna category I public sector utility, is Government of India’s flagship hydroelectric…

  3. Ashok Leyland Ltd Q2FY25; 35% rise in Profits

    Ashok Leyland is the flagship Company of the Hinduja group, having a long-standing presence in…